These findings suggest that, although MBCs arising in male BRCA1/2 mutation carriers seem to be very similar to MBCs arising in the general population, according to morphologic and immunophenotypic features, they represent a subgroup characterised by aggressive biology. The gene discussed is BRCA1; the disease is maternal uniparental disomy of chromosome 20.